The Trauma Center at Banner Good Samaritan Medical Center is proud to be involved in research projects designed to prevent injuries and improve trauma care.
Banner Good Samaritan and the University of Arizona's Emergency Medicine Research Center are currently partnering on a traumatic brain injury (TBI) study. Progesterone for the Treatment of Traumatic Brain Injury (ProTECT III) is a research study to determine if progesterone, a hormone normally found in our bodies, is useful in limiting the amount of brain damage from TBI. Many animal studies and two small studies in humans suggest that progesterone, given after TBI, may result in less brain damage. The ProTECT III study will test these findings and determine how helpful this treatment is in adults with moderate to severe TBI.
Centers in Arizona to test brain injury drug in $14.5M study
azcentral.com (Scottsdale, Jan. 25, 2011)